Nailing down the genetic and immunological basis for psoriatic disease

Dermatology

Volumn 221, Issue SUPPL. 1, 2010, Pages 15-22

  McGonagle, Dennis ^a   Palmou Fontana, Natalia ^c   Tan, Ai Lyn ^a   Benjamin, Michael ^b  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

HLA Cw6; Nail and joint; Nail psoriasis; Pathophysiology; Psoriasis

Indexed keywords

HLA ANTIGEN; HLA CW6 ANTIGEN; UNCLASSIFIED DRUG; HLA C ANTIGEN; HLA-C*06 ANTIGEN;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; NAIL DISEASE; PRIORITY JOURNAL; PSORIASIS; REVIEW; ANATOMY AND HISTOLOGY; BIOMECHANICS; GENETICS; HUMAN; IMMUNOLOGY; MALE; NAIL; PATHOLOGY; PHENOTYPE; PSORIATIC ARTHRITIS; YOUNG ADULT;

ADAPTIVE IMMUNITY; ARTHRITIS, PSORIATIC; BIOMECHANICS; HLA-C ANTIGENS; HUMANS; IMMUNITY, INNATE; MALE; NAIL DISEASES; NAILS; PHENOTYPE; PSORIASIS; YOUNG ADULT; BIOMECHANICAL PHENOMENA;

EID: 77956041854     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316171     Document Type: Review

References (46)

1. Wright V: Psoriasis and arthritis. Ann Rheum Dis 1956; 15: 348-356.
2. Gisondi P, Tinazzi I, El-Dalati G, et al: Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital- based case-control study. Ann Rheum Dis 2008; 67: 26-30.
3. Scarpa R, Ayala F, Caporaso N, Olivieri I: Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol 2006; 33: 210-212.
4. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY: Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007; 57: 1-27.
5. Zaias N: Nail in Health and Disease, ed 2. London, Appleton and Lange, 1990.
6. de Berker DA, Andre J, Baran R: Nail biology and nail science. Int J Cosmet Sci 2007; 29: 241-275.
7. Fleckman P: Structure and function of the nail unit; in Scher RK, Daniel CR III (eds): Nails: Diagnosis, Therapy, Surgery, ed 3. Philadelphia, Elsevier, 2005, pp 13-26.
8. Martin BF, Platts MM: A histological study of the nail region in normal human subjects and in those showing splinter haemorrhages of the nail. J Anat 1959; 93: 323-330.
9. Frenz C, Fritsch H, Hoch J: Plastination histologic investigations on the inserting pars terminalis aponeurosis dorsalis of three - sectioned fingers. Ann Anat 2000; 182: 69-73.
10. Tan AL, Benjamin M, Toumi H, et al: The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis - a high-resolution MRI and histological study. Rheumatology (Oxford) 2007; 46: 253-256.
11. McGonagle D, Tan AL, Benjamin M: The nail as a musculoskeletal appendage - implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 2009; 218: 97-102.
12. Tan AL, Grainger AJ, Tanner SF, Emery P, McGonagle D: A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum 2006; 54: 1328-1333.
13. McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P: Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 1998; 41: 694-700.
14. Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O: Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd- DTPA) magnetic resonance imaging. Skeletal Radiol 1995; 24: 351-355.
15. McGonagle D: Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis. Ann Rheum Dis 2005; 64:ii58-ii60.
16. Benjamin M, McGonagle D: The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 2001; 199: 503-526.
17. Benjamin M, McGonagle D: Histopathologic changes at 'synovio-entheseal complexes' suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis. Arthritis Rheum 2007; 56: 3601-3609.
18. Benjamin M, Toumi H, Suzuki D, Redman S, Emery P, McGonagle D: Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders. Arthritis Rheum 2007; 56: 224-233.
19. McGonagle D, Lories RJ, Tan AL, Benjamin M: The concept of a 'synovio-entheseal complex' and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 2007; 56: 2482-2491.
20. Raychaudhuri SP, Jiang WY, Raychaudhuri SK: Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis (comment). Am J Pathol 2008; 172: 961-971.
21. Baker BS, Powles AV, Lambert S, Valdimarsson H, Fry L: A prospective study of the Koebner reaction and T lymphocytes in uninvolved psoriatic skin. Acta Derm Venereol 1988; 68: 430-434.
22. Sahin GO, Akyol M, Ozcelik S: An unusual Koebner phenomenon secondary to PPD with pustular and arthropathic psoriasis. Eur J Dermatol 2007; 17: 446.
23. Fawcett RS, Linford S, Stulberg DL: Nail abnormalities: clues to systemic disease. Am Fam Physician 2004; 69: 1417-1424.
24. Marcilly MC, Balme B, Haftek M, et al: Subtotal hereditary leukonychia, histopathological and electron microscopy study of 'milky' nails. Ann Dermatol Venereol 2003; 130: 50-54.
25. Samman PD, Fenton DA (eds): The Nail in Disease. London, William Heinemann, 1986.
26. Baran R, Dawber RPR (eds): Diseases of the Nail and Their Management. Oxford, Blackwell Scientific Publications, 1984.
27. Lewin K, DeWit S, Ferrington RA: Pathology of the finger nail in psoriasis: a clinicopathological study. Br J Dermatol 1972; 86: 555-563.
28. Namey TC, Rosenthall L: Periarticular uptake of 99mtechnetium diphosphonate in psoriatics: correlation with cutaneous activity. Arthritis Rheum 1976; 19: 607-612.
29. McGonagle D, Marzo-Ortega H, Benjamin M, Emery P: Report on the Second International Enthesitis Workshop. Arthritis Rheum 2003; 48: 896-905.
30. Mahoney JM, Scott R: Psoriatic onychopachydermoperiostitis (POPP): a perplexing case study. J Am Podiatr Med Assoc 2009; 99: 140-143.
31. Resnick D, Broderick TW: Bony proliferation of terminal toe phalanges in psoriasis: the 'ivory' phalanx. J Can Assoc Radiol 1977; 28: 187-189.
32. McGonagle D, Conaghan PG, Emery P: Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999; 42: 1080-1086.
33. Jury CS, Fleming C, Kemmett D: Severe nail dystrophy associated with painful fingertips. Diagnosis: psoriatic onychopachydermoperiostitis (POPP). Arch Dermatol 2000; 136: 925-930.
34. Srivastava M, Solomon G, Strober B: Psoriatic onycho-pachydermo periostitis. Dermatol Online J 2007; 13: 20.
35. Bongartz T, Harle P, Friedrich S, et al: Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab. Arthritis Rheum 2005; 52: 280-282.
36. Marzo-Ortega H, McGonagle D, Rhodes LA, et al: Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis. Ann Rheum Dis 2007; 66: 778-781.
37. Elder JT: Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun 2009; 10: 201-209.
38. Gudjonsson JE, Karason A, Antonsdottir AA, et al: HLA-Cw6-positive and HLACw6- negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 2002; 118: 362-365.
39. Fan X, Yang S, Sun LD, et al: Comparison of clinical features of HLA-Cw * 0602-positive and -negative psoriasis patients in a Han Chinese population. Acta Derm Venereol 2007; 87: 335-340.
40. Ho PY, Barton A, Worthington J, Thomson W, Silman AJ, Bruce IN: HLA-Cw6 and HLA-DRB1 * 07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis 2007; 66: 807-811.
41. Filer C, Ho P, Smith RL, et al: Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum 2008; 58: 3705-3709.
42. McGonagle D, McDermott MF: A proposed classification of the immunological diseases. PLoS Med 2006; 3:e297.
43. McGonagle D, Georgouli T: The importance of 'Mechnikov's thorn' for an improved understanding of 21st century medicine and immunology: a view from the eye. Scand J Immunol 2008; 68: 129-139.
44. Lawry M: Biological therapy and nail psoriasis. Dermatol Ther 2007; 20: 60-67.
45. Rigopoulos D, Gregoriou S, Stratigos A, et al: Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study. Br J Dermatol 2008; 159: 453-456.
46. Rich P, Griffiths CEM, Reich K, et al: Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 2008; 58: 224-231.